2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Genetic Disorders: new trials by email Literature Review of Genetic Disorders trials Research Report on Genetic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema recombinant human C1 inhibitor, Placebo - Hereditary Angioedema, Angioneurotic Edema | Phase 3 | Completed | Pharming Technologies B.V. | 75 | 2004-06-01 | 2012-10-02 |
| Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema i.v. recombinant human C1 inhibitor - Genetic Disorders | Phase 2 / Phase 3 | Completed | Pharming Technologies B.V. | 14 | 2004-04-01 | 2013-02-22 |
Genetic Diseases, Inborn (2) · Angioedema (1) · Angioedemas, Hereditary (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Cardiovascular Diseases (1) · Hereditary Complement Deficiency Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Primary Immunodeficiency Diseases (1) · Skin Diseases (1) · Skin Diseases, Vascular (1) · Skin and Connective Tissue Diseases (1) · Urticaria (1) · Vascular Diseases (1)
Complement C1 Inhibitor Protein (1) · Sodium Chloride (1) · conestat alfa (1)
Pharming Technologies B.V. (2)
Netherlands (2) · Romania (1)